Objectives: To investigate the relationship between hearing loss and cardiovascular disease risk factors.
Cardiovascular disease (CVD) and hearing loss (HL) are common conditions amongst older adults. Rosen suggested the relationship between CVD and HL after identifying superior hearing in the southeast Sudanese Mabaan tribe, where CVD was less prevalent compared to similarly aged people in the United States. 1 It is hypothesised that reduced blood supply to the stria vascularis of the cochlea due to CVD can lead to impairment of inner-ear function, resulting in HL. [2] [3] [4] Previous studies have found that cardiovascular-related HL may be greater at lower frequencies (250-2000 Hz). [2] [3] [4] The distal part of the cochlea responsible for low-frequency sound transduction has less capillary vessels and is therefore more sensitive to ischaemia. [2] [3] [4] Histopathological studies on human and mice temporal bones have demonstrated that the cochlea microvasculature undergoes physical degenerative changes in the atherosclerotic patient and diabetic patient. 5, 6 The aim of this study was to determine the association between cardiovascular risk factors and HL.
2 | ME TH ODS
| Population and study sample
A community-based cross-sectional survey of adults born within 1946-1964 residing in Busselton, Western Australia, was undertaken from May 2010 to December 2015. The details of the study protocol and methods are described by James et al. 7 The survey invited all eligible adults registered on the compulsory national electoral roll. Contact was made with 82% of those eligible and 76% of those contacted participated. The study received ethics approval from The University of Western Australia Human
Research Ethics Committee (Number RA/4/1/2203), and written informed consent was obtained from each participant. There were 5107 participants; 4877 had data on all required variables and were included in analyses.
| Demographic and health history variables
Gender, age, smoking history, alcohol history, history of diabetes, cardiac disease, cerebrovascular accident, current medications (cholesterol-and blood pressure-lowering) and family history of HL were obtained by questionnaire. A participant was considered to have a history of CVD if positive for self-reported cardiac disease or cerebrovascular accident or with measured peripheral arterial disease.
| Subjective variables
Self-reported HL, tinnitus and hyperacusis were assessed via questionnaire as follows:
• Self-reported HL was defined positive if participant responded "yes" to "do you have a hearing loss?" and "frequently" or "constantly" to "does it affect your daily life and activities?"
• Tinnitus was defined positive if participant responded "yes" to "do you experience tinnitus (sound in your ears and head) for longer than 5 minutes which does not have an obvious cause?"
and "frequently" or "constantly" to "how does tinnitus affect your daily life and activities?"
• Hyperacusis was defined positive if participant responded "yes"
to "do you consider yourself sensitive or intolerant to everyday sounds?" and "frequently" or "constantly" to "how often does it affect your daily life and activities?"
| Measured variables
A hearing assessment included pure-tone air conduction audiometry with masking using an Automated Method for Testing Auditory Sensitivity in a sound-treated booth (Appendix S1). 8, 9 The definitions of measured variables are listed in • High-density lipoprotein may have a possible protective effect on hearing loss.
• There is a graded association between overall cardiovascular risk score and hearing loss.
• Otolaryngologists should actively encourage patients to reduce modifiable cardiovascular risk factors.
presented as estimated effects (b coefficients) with a 95% CI. All risk factors are assessed after adjusting for age, sex and family history of HL, as these were found to be strong determinants of all hearing outcomes. Detailed statistical methodology and results are presented for the total sample and for the CVD-free sample (Appendix S1).
| RESULTS
Sample characteristics are presented in Table 2 . Participants ranged in age from 45 to 69 years with a mean of 58 years, and 54% female.
| Subjective variables
Overall, 4.3% self-reported HL, 2.0% reported tinnitus, and 1.7%
reported hyperacusis (Table 2) . Self-reported HL (6.8% vs 2.2%, P<0.001) and tinnitus (3.0% vs 1.2%, P<0.001) were more prevalent in men, but the self-reported prevalence of hyperacusis was similar in men and women (1.6% vs 1.8%, P=0.542). All self-reported hearing outcomes worsened (P<0.05) with increasing age in men but not in women (P>0.05; Table 3 ). There was a progressive worsening (P<0.001) of all self-reported hearing outcomes with increasing number of first-degree relatives with HL in both genders except for selfreported hyperacusis in women (P=0.833; Table 4 ). Table 3 ) and with increasing number of first-degree relatives with HL (P<0.01; Table 4) in both genders.
The risk factors significantly associated with all three audiometric averages were current smoking, a history of peripheral arterial disease, a history of CVD and obesity (BMI, waist circumference, high waist circumference). In the best ear pure-tone average and low-frequency average, high triglyceride, high fasting blood glucose, high glycated haemoglobin and high blood pressure were also significantly associated. Lastly, in the best ear high-frequency average, alcohol use was also significantly associated. Increased high-density lipoprotein levels were associated with reduced level of HL (Table 6 ).
All three audiometric averages showed a significant graded asso- 
| Comparisons with other studies
Increasing age, male gender and family history are three well-known risk factors for HL that we adjusted for. 12, 13 In age-related HL, other well-known risk factors include environmental or occupational noise exposure, and exposure to cochlear toxins such as ototoxic
T A B L E 1 Definitions of the measured variables used

Measured variable Definition
Best ear pure-tone average (dB) NKCC1 ion channels). 16 In a mouse model of spiral ganglion cell apoptosis, aldosterone therapy was found to improve hearing thresholds as maintaining aldosterone levels, which normally decline with age, improved spiral ganglion cell survival via upregulating mineralocorticoid receptors in the cochlea and blocking apoptotic pathways. 16 However, this conflicts with cardiovascular literature, which largely points to elevated aldosterone levels causing a multitude of CVD. 17 Oxidative stress was a key mechanism found to induce mitochronidal apoptosis in the cochlear spiral ganglion and hair cells of C57BL/6J mice, and oral supplementation of antioxidants delayed cochlear cell death and the onset of HL. 18 Lastly, as low-grade inflammation and microvessel pathology in the cochlea microvasculature remains a predominant theory, a randomised clinical trial seeks to test the role of low-dose aspirin as a preventative therapy for presbycusis. 19 The trial will provide important data for our understanding of CVD-related HL and potential future treatment possibilities. 
| Tobacco smoking
Current smoking was associated with measured HL and hyperacusis.
However, being a previous smoker was not associated, providing possible evidence for the benefits of smoking cessation. Smoking as a risk factor for HL is well documented. 12, 13, 21 The relationship with smoking is thought to be exposure-dependent and stronger in patients with concurrent diabetes. 12, 13 Diabetes and smoking have been observed to cause endothelial dysfunction (reduced vasodilation to endothelial stimuli). 22 Smoking may also affect hearing through carbon monoxide-induced hypoxic strain placed on hair cells and the direct ototoxic effects of nicotine on hair cell function and neurotransmission of auditory stimuli. 21 A retrospective review found ex-smokers who had quit for >5 years (compared to <5 years)
were of similar risk to non-smokers for HL and complications postotologic surgery. 23 However, while smoking cessation returns the risk for coronary heart disease to that of a non-smoker after 15 years, as the inner ear does not regenerate, it is unclear whether the overall HL effects from smoking are reversible. 24 
| Diabetes mellitus
Diabetes was associated with self-reported HL, tinnitus, pure-tone and low-frequency HL. A meta-analysis identified that HL was two times more likely in diabetic patients regardless of age. 25 A cohort study found poor glycaemic control, as well as central adiposity and smoking to increase the risk of hearing impairment. 26 Diabetes mellitus is thought to induce cellular damage from oxidative stress, endothelial dysfunction and hyperglycaemia itself. 27 Changes from diabetes mellitus are mostly seen as atrophy of the stria vascularis and thickening of vascular basement membranes. 27 This leads to impaired endocochlear potential generation and hair cell transduction. 27 
| Hypertension
A history of CVD was associated with measured HL. This is consistent with other studies, specifically for myocardial infarction. 2, 28 A previous study identified that HL was associated with a history of CVD and hypertension, while in females, it was also associated with a higher systolic blood pressure, higher blood glucose and low levels of high-density lipoprotein. 3 Higher systolic and diastolic blood pressure was associated with low-frequency and pure-tone average HL. As a whole, high-frequency HL was associated with less cardiovascular risk factors compared to low frequency, findings that have been echoed by other studies. 2, 3 This may be explained by the nature of the cochlear apex, the region responsible for low-frequency hearing, being more sensitive to ischaemia.
| Dyslipidaemia
High cholesterol and taking cholesterol medication were associated with subjective HL. Previous studies have highlighted the association between hyperlipidaemia and HL, with one concluding that low cholesterol levels were protective. 1, 29 We found a possible protective effect with high-density lipoprotein. Cholesterol can impair microcirculation via atherosclerosis, and by decreasing the release of nitric oxide, a vasodilator produced from endothelial cells. 30 The positive relationship between high cholesterol and HL has been previously reported; however, cholesterol-lowering medication failed to show a reduction in HL in a randomised study. 
| Strengths and limitations of the study
The "baby boomer" generation born 1946-1964 is a unique age group to investigate associations between cardiovascular risk factors and HL in ageing due to the increasing prevalence of these conditions with age. The large sample size, high participation and protocol completion rate and detailed measurements of variables were our strengths.
This study was limited by the characteristics of the Busselton baby boomer population, namely its narrow age range, racial and specific geographical setting. The subjective nature of questionnaire-based data collection may introduce bias.
As this is a cross-sectional study, only associations between HL and CVD can be studied. Prospective studies using longitudinal data should test the direction of the association between HL and CVD.
T A B L E 6 Adjusted associations between measured hearing loss and cardio-metabolic risk factors (total sample) Further research is required to explore the potential underlying pathophysiology of HL due to CVD; and subsequently, medications that could target specific biochemical pathways to reduce HL.
| Clinical applicability of the study
Recent research has examined hearing impairment as a sign of circulatory instability. 15 The inner ear is considered a sensory neural organ that is sensitive to systemic pathology such as cardio-metabolic, autoimmune or inflammatory conditions. 15 A multidisciplinary approach to managing HL is required, and medications targeting the cardiovascular system may have a future role in preventing HL. 19 HL may become an early marker for CVD if future studies demonstrate that HL precedes the onset of cardiovascular events.
On the other hand, restoration of blood supply to the cochlea through better cardiovascular fitness, reversing modifiable cardiovascular risk factors, or treating CVD earlier may protect against HL.
Addressing CVD risk factors may be beneficial in patients with an already increased pre-disposition to HL due to positive family history. Our study uniquely relates HL with overall cardiovascular risk through the Framingham Risk Score, separating our findings from current literature, which report individual CVD risk factors for HL in isolation to one another. As the Framingham Risk Score is a commonly used tool in community medicine, translation of our findings to educate patients on the benefits of reducing overall CVD risk is made easier. The graded association infers that the higher the risk of cardiac events, the higher the risk of HL. Thus, targeting modifiable CVD risk factors (eg, by encouraging smoking cessation and weight loss) may positively impact the risk of HL.
| CONCLUSION
In this Australian population-based cross-sectional study, a CVD history and nearly all modifiable CVD risk factors were associated with
HL. An overall increased CVD risk profile is a strong determinant of HL. We therefore suggest Otolaryngologists consider modifiable CVD risk factors as treatable causes of hearing loss, and as such actively encourage their patients to reduce their overall cardiovascular risk.
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